EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Downregulated MECR Gene in Parkinson’s Disease Through Integrated Transcriptomic Analysis and Validation

Danlei Wang, Haoheng Yu, Yi Qu, Ke An, Hongming Liang, Zhijuan Mao, Jingyi Li, Yongjie Xiong, Zhe Min, Zheng Xue

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26020550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Danlei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Parkinson Disease, Down-Regulation, Transcriptome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic neuron degeneration and α-synuclein (α-syn) aggregation. Lipid metabolism dysfunction may contribute to PD progression. This study aims to identify lipid metabolism-related genes (LMGs) associated with PD using an integrative transcriptomic analysis of microarray and single-cell RNA sequencing (scRNA-seq) datasets from patients with PD and healthy controls. Differentially expressed genes (DEGs) related to lipid metabolism were identified, and key genes were further filtered using weighted gene co-expression network analysis (WGCNA) and machine learning algorithms. Four LMGs, AGPAT2, ASAH2, FA2H, and MECR were identified, with MECR being notably downregulated in both bulk and single-cell transcriptomic analyses of PD patients. This downregulation was further validated in α-syn PFF-induced PD models. Virtual screening and molecular simulations identified potential allosteric modulators of MECR, which may offer a pathway for future therapeutic exploration. This study highlights MECR as a critical gene link between lipid metabolism dysfunction and PD, suggesting the need for further investigation into its therapeutic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDown-RegulationTranscriptomeHumansGene Expression ProfilingLipid MetabolismGene Regulatory Networksalpha-SynucleinSingle-Cell AnalysisMaleAnimals

Stichwörter der Autor:innen

MECRParkinson’s diseasedrug screeninglipid metabolismmachine learning

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Department of General Practice, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, D., Yu, H., Qu, Y., An, K., Liang, H., Mao, Z., Li, J., Xiong, Y., Min, Z., & Xue, Z. (2025). Identification of Downregulated MECR Gene in Parkinson’s Disease Through Integrated Transcriptomic Analysis and Validation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020550

Vancouver

Wang D, Yu H, Qu Y, An K, Liang H, Mao Z, et al. Identification of Downregulated MECR Gene in Parkinson’s Disease Through Integrated Transcriptomic Analysis and Validation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020550

BibTeX
@article{Wang2025,
  author = {Wang, Danlei and Yu, Haoheng and Qu, Yi and An, Ke and Liang, Hongming and Mao, Zhijuan and Li, Jingyi and Xiong, Yongjie and Min, Zhe and Xue, Zheng},
  title = {Identification of Downregulated MECR Gene in Parkinson’s Disease Through Integrated Transcriptomic Analysis and Validation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26020550}
}
Kostenlos starten →